Evidence map›Paper›PMID 39796135›Full record

ArticleInternational journal of molecular sciences2024

Analyses of the

Chidinma Nganya, Sahia Bryant, Ayah Alnakhalah, Taylor Allen-Boswell, Sierra Cunningham, Samuel Kanu, Ashton Williams, Deshai Philio, Kathy Dang, Emmanuel Butler and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chidinma NganyaDepartment of Biology, Texas Southern University, Houston, TX 77004, USA.
Sahia BryantDepartment of Biology, Texas Southern University, Houston, TX 77004, USA.
Ayah AlnakhalahDepartment of Biology, Texas Southern University, Houston, TX 77004, USA.
Taylor Allen-BoswellDepartment of Biology, Texas Southern University, Houston, TX 77004, USA.
Sierra CunninghamDepartment of Biology, Texas Southern University, Houston, TX 77004, USA.
Samuel KanuDepartment of Biology, Texas Southern University, Houston, TX 77004, USA.
Ashton WilliamsDepartment of Biology, Texas Southern University, Houston, TX 77004, USA.
Deshai PhilioDepartment of Biology, Texas Southern University, Houston, TX 77004, USA.
Kathy DangDepartment of Biology, Texas Southern University, Houston, TX 77004, USA.
Emmanuel ButlerDepartment of Biology, Texas Southern University, Houston, TX 77004, USA.
Audrey PlayerDepartment of Biology, Texas Southern University, Houston, TX 77004, USA.ORCID 0009-0008-3299-6670

Funding

Comparative analyses of MYBL1 knockdown in non-tumor and triple negative breast cancer cellsR16GM145612 · NIGMS · TEXAS SOUTHERN UNIVERSITY · PI PLAYER, AUDREY · 2022 to 2024
$368k
NIGMS NIH HHS R16 GM145612NIH HHS 2R16GM145612-25A1
6 · The paper itself

Abstract

Previous data show that the knockdown of the

Indexed as

Cell Cycle ProteinsExonsGene Expression Regulation, NeoplasticTriple Negative Breast NeoplasmsBinding SitesCell Line, TumorFemaleHumansPromoter Regions, GeneticValosin Containing ProteinCell Cycle ProteinsValosin Containing ProteinVCP protein, humantriple negative breast cancer (TNBC)tumor-associated exonsValosin-Containing Protein P97/P47 Complex-Interacting Protein 1 (VCPIP1)V-Myb Avian Myeloblastosis Viral Oncogene Homolog-Like 1 (MYBL1)

Identifiers

PMID39796135
PMCPMC11719811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.